Condizione: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Condizione: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
Da: Basi6 International, Irving, TX, U.S.A.
Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Condizione: New. Brand New Original US Edition. Customer service! Satisfaction Guaranteed.
Condizione: New. pp. 288.
Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Da: Majestic Books, Hounslow, Regno Unito
EUR 105,21
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: New. pp. 288.
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 105,37
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: New. pp. 288.
Da: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 145,54
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: new.
Da: GreatBookPrices, Columbia, MD, U.S.A.
EUR 159,02
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Da: GreatBookPrices, Columbia, MD, U.S.A.
EUR 159,73
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Da: PBShop.store UK, Fairford, GLOS, Regno Unito
EUR 159,07
Quantità: 15 disponibili
Aggiungi al carrelloHRD. Condizione: New. New Book. Shipped from UK. Established seller since 2000.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 157,23
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Lingua: Inglese
Editore: Edward Elgar Publishing Ltd, 2016
ISBN 10: 1785369385 ISBN 13: 9781785369384
Da: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
EUR 158,89
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. 2016. Hardback. . . . . .
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 160,94
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Da: Revaluation Books, Exeter, Regno Unito
EUR 171,10
Quantità: 2 disponibili
Aggiungi al carrelloHardcover. Condizione: Brand New. 266 pages. 9.25x6.25x0.75 inches. In Stock.
Lingua: Inglese
Editore: Edward Elgar Publishing Ltd, GB, 2016
ISBN 10: 1785369385 ISBN 13: 9781785369384
Da: Rarewaves.com USA, London, LONDO, Regno Unito
EUR 184,10
Quantità: 9 disponibili
Aggiungi al carrelloHardback. Condizione: New. One of the major shortcomings of the current drug discovery and development process is the inability to bridge the gap between early stage discoveries and pre-clinical research to advance innovations beyond the discovery phase. This book examines a novel drug discovery and development model where the respective expertise of academia and industry are brought together to take promising discoveries through to proof of concept as a way to de-risk the drug discovery and development process.Expert author Helen Yu explores integrated drug discovery by analyzing the intersection of intellectual property law and competition law and discusses the role of stakeholders in efficient translation and commercialization of publically funded research. Considering the transactional risks associated with drug discovery and development, this book advocates for a greater emphasis on contractual freedom and economic efficiency when assessing collaborative partnerships between industry and public research organizations. This standout book bridges the gap between theoretical research and legal practice by providing a research-based applied perspective on university-industry collaborations in drug discovery and development.Achieving Proof of Concept in Drug Discovery and Development has an international appeal, especially in countries actively involved in drug discovery and development, such as the United States, the United Kingdom, Switzerland, Germany, Japan, India and China. Organizations and associations in the drug discovery and development field would likely be interested in reading a book that provides a research-based applied perspective as well.
Lingua: Inglese
Editore: Edward Elgar Publishing Ltd, Cheltenham, 2016
ISBN 10: 1785369385 ISBN 13: 9781785369384
Da: Grand Eagle Retail, Bensenville, IL, U.S.A.
Hardcover. Condizione: new. Hardcover. One of the major shortcomings of the current drug discovery and development process is the inability to bridge the gap between early stage discoveries and pre-clinical research to advance innovations beyond the discovery phase. This book examines a novel drug discovery and development model where the respective expertise of academia and industry are brought together to take promising discoveries through to proof of concept as a way to de-risk the drug discovery and development process.Expert author Helen Yu explores integrated drug discovery by analyzing the intersection of intellectual property law and competition law and discusses the role of stakeholders in efficient translation and commercialization of publically funded research. Considering the transactional risks associated with drug discovery and development, this book advocates for a greater emphasis on contractual freedom and economic efficiency when assessing collaborative partnerships between industry and public research organizations. This standout book bridges the gap between theoretical research and legal practice by providing a research-based applied perspective on university-industry collaborations in drug discovery and development.Achieving Proof of Concept in Drug Discovery and Development has an international appeal, especially in countries actively involved in drug discovery and development, such as the United States, the United Kingdom, Switzerland, Germany, Japan, India and China. Organizations and associations in the drug discovery and development field would likely be interested in reading a book that provides a research-based applied perspective as well. One of the major shortcomings of the current drug discovery and development process is the inability to bridge the gap between early stage discoveries and pre-clinical research in order to advance innovations beyond the discovery phase. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Lingua: Inglese
Editore: Edward Elgar Publishing Ltd, 2016
ISBN 10: 1785369385 ISBN 13: 9781785369384
Da: THE SAINT BOOKSTORE, Southport, Regno Unito
EUR 170,29
Quantità: Più di 20 disponibili
Aggiungi al carrelloHardback. Condizione: New. New copy - Usually dispatched within 4 working days.
Lingua: Inglese
Editore: Edward Elgar Publishing Ltd, 2016
ISBN 10: 1785369385 ISBN 13: 9781785369384
Da: Kennys Bookstore, Olney, MD, U.S.A.
EUR 206,31
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. 2016. Hardback. . . . . . Books ship from the US and Ireland.
Lingua: Inglese
Editore: Edward Elgar Publishing Ltd, GB, 2016
ISBN 10: 1785369385 ISBN 13: 9781785369384
Da: Rarewaves.com UK, London, Regno Unito
EUR 173,79
Quantità: 9 disponibili
Aggiungi al carrelloHardback. Condizione: New. One of the major shortcomings of the current drug discovery and development process is the inability to bridge the gap between early stage discoveries and pre-clinical research to advance innovations beyond the discovery phase. This book examines a novel drug discovery and development model where the respective expertise of academia and industry are brought together to take promising discoveries through to proof of concept as a way to de-risk the drug discovery and development process.Expert author Helen Yu explores integrated drug discovery by analyzing the intersection of intellectual property law and competition law and discusses the role of stakeholders in efficient translation and commercialization of publically funded research. Considering the transactional risks associated with drug discovery and development, this book advocates for a greater emphasis on contractual freedom and economic efficiency when assessing collaborative partnerships between industry and public research organizations. This standout book bridges the gap between theoretical research and legal practice by providing a research-based applied perspective on university-industry collaborations in drug discovery and development.Achieving Proof of Concept in Drug Discovery and Development has an international appeal, especially in countries actively involved in drug discovery and development, such as the United States, the United Kingdom, Switzerland, Germany, Japan, India and China. Organizations and associations in the drug discovery and development field would likely be interested in reading a book that provides a research-based applied perspective as well.
Lingua: Inglese
Editore: Edward Elgar Publishing Ltd, Cheltenham, 2016
ISBN 10: 1785369385 ISBN 13: 9781785369384
Da: AussieBookSeller, Truganina, VIC, Australia
EUR 272,54
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: new. Hardcover. One of the major shortcomings of the current drug discovery and development process is the inability to bridge the gap between early stage discoveries and pre-clinical research to advance innovations beyond the discovery phase. This book examines a novel drug discovery and development model where the respective expertise of academia and industry are brought together to take promising discoveries through to proof of concept as a way to de-risk the drug discovery and development process.Expert author Helen Yu explores integrated drug discovery by analyzing the intersection of intellectual property law and competition law and discusses the role of stakeholders in efficient translation and commercialization of publically funded research. Considering the transactional risks associated with drug discovery and development, this book advocates for a greater emphasis on contractual freedom and economic efficiency when assessing collaborative partnerships between industry and public research organizations. This standout book bridges the gap between theoretical research and legal practice by providing a research-based applied perspective on university-industry collaborations in drug discovery and development.Achieving Proof of Concept in Drug Discovery and Development has an international appeal, especially in countries actively involved in drug discovery and development, such as the United States, the United Kingdom, Switzerland, Germany, Japan, India and China. Organizations and associations in the drug discovery and development field would likely be interested in reading a book that provides a research-based applied perspective as well. One of the major shortcomings of the current drug discovery and development process is the inability to bridge the gap between early stage discoveries and pre-clinical research in order to advance innovations beyond the discovery phase. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.